CUSIP: 43358V109
Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
37,932,903
-
Share change
-
+27,318,922
-
Total reported value
-
$7,254,000
-
Price per share
-
$0.19
-
Number of holders
-
18
-
Value change
-
+$5,380,977
-
Number of buys
-
5
-
Number of sells
-
11
Quarterly Holders Quick Answers
What is CUSIP 43358V109?
CUSIP 43358V109 identifies HSGX - HISTOGENICS CORP - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2019
-
Previous quarter:
Q1 2019
Recent filing periods for CUSIP 43358V109:
Institutional Holders of HISTOGENICS CORP - COM (HSGX) as of Q2 2019
As of 30 Jun 2019,
HISTOGENICS CORP - COM (HSGX) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,932,903 shares.
The largest 10 holders included
CVI Holdings, LLC, VANGUARD GROUP INC, Virtu Financial LLC, Abingworth LLP, GEODE CAPITAL MANAGEMENT, LLC, Palo Alto Investors LP, PANAGORA ASSET MANAGEMENT INC, CREDIT SUISSE AG/, Rossmore Private Capital, and UNITED CAPITAL FINANCIAL ADVISERS, LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.